Financial Statements — MGX
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Cash & Equivalents | 39.03 | 25.31 | 32.77 | 26.85 | 29.20 | 25.12 | 61.18 | 102.56 |
| Accounts Receivable | 0.00 | 0.00 | 0.96 | 0.90 | 0.90 | 0.59 | 1.65 | 2.08 |
| Total Current Assets | 124.47 | 144.56 | 189.82 | 211.68 | 233.20 | 282.29 | 307.58 | 335.64 |
| Property, Plant & Equipment | 9.90 | 11.16 | 13.90 | 15.11 | 16.52 | 19.72 | 20.71 | 20.96 |
| Total Non-current Assets* | 49.23 | 52.40 | 58.12 | 60.60 | 64.67 | 76.06 | 78.33 | 79.76 |
| Total Assets | 173.70 | 196.95 | 247.94 | 272.28 | 297.87 | 358.35 | 385.91 | 415.40 |
| Accounts Payable | 2.60 | 2.40 | 1.22 | 2.89 | 2.67 | 3.10 | 3.45 | 6.84 |
| Total Current Liabilities | 27.63 | 22.50 | 29.58 | 33.27 | 39.89 | 45.69 | 52.81 | 70.70 |
| Total Non-current Liabilities* | 33.50 | 36.67 | 39.91 | 43.19 | 45.32 | 56.88 | 63.68 | 69.07 |
| Total Liabilities | 61.13 | 59.17 | 69.49 | 76.45 | 85.21 | 102.58 | 116.49 | 139.77 |
| Retained Earnings | (361.41) | (333.93) | (288.34) | (267.95) | (248.04) | (199.60) | (180.83) | (170.09) |
| Total Stockholder Equity | 112.57 | 137.79 | 178.45 | 195.83 | 212.66 | 255.77 | 269.42 | 275.63 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Total Revenue | -- | 1.25 | 3.91 | 8.66 | 8.51 | 4.13 | 9.61 | 11.51 | 20.01 | 11.16 |
| Research & Development | 22.51 | 19.30 | 21.50 | 25.28 | 22.51 | 25.14 | 23.16 | 26.26 | 28.32 | 31.44 |
| Selling, General & Admin | 6.00 | 6.54 | 6.78 | 6.22 | 6.99 | 6.81 | 7.07 | 7.64 | 8.55 | 8.75 |
| Total Operating Expenses | 28.52 | 25.84 | 28.28 | 31.50 | 29.50 | 31.95 | 30.24 | 33.90 | 36.87 | 40.19 |
| Operating Income | (28.77) | (24.59) | (24.37) | (22.84) | (20.99) | (27.82) | (20.62) | (22.38) | (16.86) | (29.03) |
| Pretax Income | (27.48) | (23.05) | (22.49) | (20.63) | (19.86) | (24.94) | (24.61) | (20.88) | (12.94) | (25.15) |
| Tax Provision | 0.00 | 0.01 | 0.03 | (0.23) | 0.04 | 0.10 | (1.21) | (2.11) | (2.20) | 0.00 |
| Net Income | (27.48) | (23.06) | (22.53) | (20.39) | (19.91) | (25.04) | (23.40) | (18.77) | (10.74) | (25.15) |
| Basic EPS | (0.73) | (0.61) | (0.59) | (0.55) | (0.54) | (0.68) | (0.37) | (0.51) | (0.29) | (1.19) |
| Diluted EPS | (0.73) | (0.61) | (0.59) | (0.55) | (0.54) | (0.68) | (0.37) | (0.51) | (0.29) | (1.19) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Operating Cash Flow | (19.51) | (21.17) | (23.55) | (21.25) | (21.25) | (22.84) | (26.28) | (26.64) | (26.31) | (29.85) |
| Capital Expenditures | 0.13 | 0.03 | 0.09 | 0.07 | 0.13 | 0.29 | 0.33 | 1.20 | 0.67 | 0.92 |
| Free Cash Flow* | (19.64) | (21.20) | (23.63) | (21.33) | (21.38) | (23.13) | (26.61) | (27.84) | (26.97) | (30.76) |
| Investing Cash Flow | 33.17 | 3.99 | 32.37 | 27.36 | 19.07 | 24.73 | 28.55 | (8.93) | (13.04) | (94.73) |
| Financing Cash Flow | 0.07 | (0.03) | 0.07 | (0.19) | (0.17) | (0.08) | 0.00 | (0.49) | (2.03) | 86.54 |
* Derived from reported values
